Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial
Alì Taher(American University of Beirut Medical Center), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Abderrahim Khélif(Ente Ospedaliero Ospedali Galliera), John B. Porter(Royal London Hospital), Jeevan K. Shetty(Ente Ospedaliero Ospedali Galliera), Antonio Piga(University of Turin), Antonis Kattamis, Jay T. Backstrom(Université Paris Cité), Kevin H.M. Kuo(University Health Network), Olivier Hermine(Centre National de la Recherche Scientifique), Thomas D. Coates(Children's Hospital of Los Angeles), Vip Viprakasit(Siriraj Hospital), Dimana Miteva(Bristol-Myers Squibb (Switzerland)), George Zhang(Air Force Medical University), Yu Tian(Shanghai Chest Hospital), Ersi Voskaridou(Laiko General Hospital of Athens), Derek Tang(Bristol-Myers Squibb (Germany)), Tatiana Zinger(Incyte (United States))
Cited by 8
Related Papers
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Thalassaemia
|The Lancet|2017|763